In this podcast series sponsored by Biopharmaceutical Section of American Statistical Association, key opinion leaders from pharmaceutical industry and regulatory agencies talk about upcoming statistical conferences and events, and discuss current issues in Biopharmaceutical statistics.
…
continue reading
Ian describes how to leverage ChatGPT to accelerate statistical programming in the medical product industry. Related paper available here: https://www.pharmasug.org/proceedings/2024/AP/PharmaSUG-2024-AP-256.pdfKirjoittanut American Statistical Association (ASA) Biopharm. Section
…
continue reading
1
Episode 108: Working Moms
37:09
37:09
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
37:09
Elaine Hoffman, Rebbecca Wilson, Christina Nurse, and Amy LaLonde discuss the balancing act between family and career.Kirjoittanut American Statistical Association (ASA) Biopharm. Section
…
continue reading
1
Episode 107: SPAIG Committee
27:32
27:32
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
27:32
Scott Clark, Satrajit Roychoudhury, and Michelle Shardell discuss the Statistical Partnerships Among Academe, Industry & Government (SPAIG) Committee. https://community.amstat.org/spaig/homeKirjoittanut American Statistical Association (ASA) Biopharm. Section
…
continue reading
1
Episode 106: Rebbecca Wilson
40:00
40:00
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
40:00
Amy welcomes Rebbecca to the co-hosting chair while Christina enjoys some time off with her new baby (congrats)! The two discuss Rebbecca’s fascinating career thus far and how communication styles differ across male and female leaders. Reference: https://hbr.org/2022/12/research-men-speak-more-abstractly-than-women…
…
continue reading
1
Episode 105: Adrian Coles and Wendy Martinez
43:59
43:59
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
43:59
Adrian and Wendy discuss imposter syndrome and being confident in your career.Kirjoittanut American Statistical Association (ASA) Biopharm. Section
…
continue reading
1
Episode 104: Steve Ruberg
1:01:33
1:01:33
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
1:01:33
In our first episode of the new year, we interview Steve Ruberg, an ASA fellow with over 35 years of experience in the biopharmaceutical industry and an active proponent of the Tripartite Estimand Approach.Kirjoittanut American Statistical Association (ASA) Biopharm. Section
…
continue reading
Tian discusses her research in data integration methods and the bias arising from lack of representation.Kirjoittanut American Statistical Association (ASA) Biopharm. Section
…
continue reading
1
Episode 102: LaShell Robinson
36:45
36:45
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
36:45
LaShell discusses diversity, equity, and inclusion in clinical trials.Kirjoittanut American Statistical Association (ASA) Biopharm. Section
…
continue reading
1
Episode 101: Elizabeth Mannshardt-Hawk on Imposter Syndrome
45:48
45:48
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
45:48
Elizabeth discusses imposter syndrome and how to manage it in your statistical career. In collaboration with the ASA's Committee on Career Development (CCD website) .Kirjoittanut American Statistical Association (ASA) Biopharm. Section
…
continue reading
1
Episode 100: Dionne Price, ASA President-Elect
37:10
37:10
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
37:10
Dionne talks about her journey in biostatistics and her goals for the ASA when she becomes President in 2023.Kirjoittanut American Statistical Association (ASA) Biopharm. Section
…
continue reading
1
Episode 99: Amy LaLonde and Christina Nurse
33:46
33:46
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
33:46
This episode introduces new podcast cohosts Amy LaLonde and Christina Nurse! They take over hosting duties starting with Episode 101.Kirjoittanut American Statistical Association (ASA) Biopharm. Section
…
continue reading
1
Episode 98: Safety Scientific Working Group
53:45
53:45
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
53:45
James Buchanan, Judy Li, Melvin Munsaka, and Bill Wang discuss the research of the Safety Scientific Working Group and their recent edited volume "Quantitative Drug Safety and Benefit Risk Evaluation: Practical and Cross-Disciplinary Approaches." https://tinyurl.com/2ucyer95Kirjoittanut American Statistical Association (ASA) Biopharm. Section
…
continue reading
1
Episode 97 - Devan Mehrotra
49:11
49:11
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
49:11
Devan discusses the 5-STAR methodology and endpoints for COVID vaccine clinical trials.Kirjoittanut American Statistical Association (ASA) Biopharm. Section
…
continue reading
1
Episode 96: Alan Hartford
32:12
32:12
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
32:12
Alan is the 2022 Chair of the Biopharmaceutical Section. He discusses his wish list for things to accomplish this year.Kirjoittanut American Statistical Association (ASA) Biopharm. Section
…
continue reading
Anna Nevius reflects on her time at the Center for Veterinary Medicine at the FDA and as chair of the Biopharmaceutical Section in 2009.Kirjoittanut American Statistical Association (ASA) Biopharm. Section
…
continue reading
1
Episode 94: Bob Starbuck
34:29
34:29
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
34:29
Bob Starbuck reflects on his time as chair of the Biopharmaceutical Section in 1994.Kirjoittanut American Statistical Association (ASA) Biopharm. Section
…
continue reading
1
Episode 93: External Control Arms
53:53
53:53
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
53:53
Amy Xia and Lanju Zhang discuss the benefits and challenges of utilizing external control arms for clinical trials.Kirjoittanut American Statistical Association (ASA) Biopharm. Section
…
continue reading
1
Episode 92: 2021 Regulatory-Industry Statistics Workshop
35:51
35:51
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
35:51
Bo Huang and Gene Pennello discuss the 2021 Regulatory-Industry Statistics Workshop.Kirjoittanut American Statistical Association (ASA) Biopharm. Section
…
continue reading
1
Episode 91: Patient Reported Outcomes
1:02:04
1:02:04
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
1:02:04
Joseph Cappelleri and Daniel O’Connor discuss the benefits and challenges in using patient reported outcomes and how to appropriately define clinically-meaningful change.Kirjoittanut American Statistical Association (ASA) Biopharm. Section
…
continue reading
1
Episode 90: ICSA Leadership Panel
31:38
31:38
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
31:38
Haoda Fu, Mengling Liu, Jie Tang, Tian Zheng, and Kelly Zou discuss leadership and the impact of COVID-19 on the workplace.Kirjoittanut American Statistical Association (ASA) Biopharm. Section
…
continue reading
Karl Peace was chair of the Biopharmaceutical Section in 1990. He discusses his career in the industry, the Jiann-Ping Hsu College of Public Health, and the Biopharmaceutical Applied Statistics Symposium.Kirjoittanut American Statistical Association (ASA) Biopharm. Section
…
continue reading
1
Episode 88: Katherine Monti
56:50
56:50
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
56:50
Katherine Monti was chair of the Biopharmaceutical Section in 2010. She discusses her career in the industry and how the Section has changed over time.Kirjoittanut American Statistical Association (ASA) Biopharm. Section
…
continue reading
1
Episode 87: Storytelling
1:04:59
1:04:59
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
1:04:59
Scott Evans, Stephanie Omokaro, Janet Wittes, and Zhiheng Xu discuss the importance of storytelling for the modern statistician.Kirjoittanut American Statistical Association (ASA) Biopharm. Section
…
continue reading
1
Episode 86: Pediatric Drug Development Scientific Working Group
47:09
47:09
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
47:09
Meg Gamalo and Jingjing Ye talk about pediatric drug development and discuss why forming a scientific working group was so important.Kirjoittanut American Statistical Association (ASA) Biopharm. Section
…
continue reading
Weili talks about publishing, leadership, and her hopes and plans for the Biopharmaceutical Section in 2021.Kirjoittanut American Statistical Association (ASA) Biopharm. Section
…
continue reading